Intellipharmaceutics International Inc. Quarterly Accrued Liabilities, Current in CAD from Q4 2015 to Q4 2018

Taxonomy & unit
us-gaap: CAD and USD
Description
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).
Summary
Intellipharmaceutics International Inc. quarterly Accrued Liabilities, Current history and growth rate from Q4 2015 to Q4 2018.
  • Intellipharmaceutics International Inc. Accrued Liabilities, Current for the quarter ending November 30, 2018 was CA$353K, a 54.9% decline year-over-year.
Accrued Liabilities, Current, Quarterly (CAD)
Accrued Liabilities, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2018 353K -429K -54.9% Nov 30, 2018 20-F/A 2019-03-04
Q4 2017 782K +397K +103% Nov 30, 2017 20-F/A 2019-03-04
Q2 2017 516K May 31, 2017 6-K 2017-07-11
Q1 2017 625K Feb 28, 2017 6-K 2017-04-12
Q4 2016 385K -69.4K -15.3% Nov 30, 2016 20-F 2018-03-01
Q4 2015 454K Nov 30, 2015 20-F 2017-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.